GVHD and the Cornea: What Transplant Patients Need to Know
How GVHD Affects the Eyes
GVHD does not stay in one part of the body. It can reach the eyes in ways that range from mild discomfort to serious corneal damage. Understanding how and why the eyes become involved helps patients and caregivers recognize problems early and seek care before they worsen.
GVHD occurs in two main forms, and both can affect the eyes. Acute GVHD begins within weeks or months after a transplant and most often appears first in the skin, gut, and liver. Chronic GVHD begins later, sometimes months to years after transplant, and tends to last much longer. The eyes are a very common target of chronic GVHD, though acute GVHD can also cause early eye involvement.
The tear glands, called lacrimal glands, contain a high concentration of immune cells. This makes them a frequent target for donor immune cells in GVHD. Over time, the glands become scarred and produce less tear fluid. When the eye surface dries out, it becomes fragile, heals more slowly, and is at greater risk of infection and damage.
The effects of GVHD on the eye range from dryness and surface breakdown to more serious structural damage. Common findings include:
- Severe dry eye caused by tear gland damage
- Surface breakdown and poor healing of the cornea
- Scarring of the conjunctiva, the thin lining that covers the white of the eye and inner eyelids
- Corneal thinning in advanced cases
Early eye evaluation after a transplant gives your care team a baseline and the best chance of catching these changes before they progress.
Some patients have a higher chance of developing eye GVHD than others. Knowing your risk factors helps you and your care team build the right monitoring plan. Higher-risk situations include:
- Receiving a transplant from a mismatched donor
- A history of acute GVHD before chronic GVHD developed
- Female patients who received a transplant from a male donor
- Total body radiation as part of the transplant preparation
- Active GVHD in other organs such as the skin, mouth, or liver
If any of these apply to you, speak with your about scheduling an eye screening early in your recovery.
Recognizing the Signs of Eye GVHD
Eye GVHD can look and feel like many things, from mild irritation to sudden pain and vision changes. Knowing what to watch for, and when to seek urgent care, can make a real difference in protecting your sight.
Early eye GVHD is easy to overlook because the signs start out mild. You may notice a gritty or sandy feeling in the eye, a burning sensation, or vision that blurs after reading or screen time. Some patients find that over-the-counter artificial tears no longer provide relief the way they once did. These early clues are worth tracking and sharing with your medical team, even if they feel minor.
GVHD can cause the inner lining of the eyelids, the conjunctiva, to scar and stiffen. The edges of the eyelids may become rough or thickened, and the small oil glands along the lid margins can become blocked. These changes reduce the quality of the tear film and make the eye surface harder to keep moist, adding to dry eye symptoms.
When the eye stays dry for too long, small areas of the corneal surface begin to break down. Under a slit lamp exam, a specialized microscope used by eye doctors, these appear as tiny dots or spots across the cornea. Most heal with proper treatment, but some can develop into open sores called corneal ulcers, which are more serious and require prompt care.
Some symptoms in a GVHD patient require same-day evaluation. Because GVHD affects the immune system, eye infections can spread quickly and cause serious damage. Seek urgent care if you notice:
- Sharp or sudden eye pain
- A new white or gray spot on the cornea
- Sudden loss of vision or significant blurring
- Sensitivity to light that comes on quickly
- A red, hot-feeling eye with thick discharge
Do not wait for your next scheduled appointment if any of these occur. Contact your eye care team right away.
How Eye GVHD Is Diagnosed
Diagnosing eye GVHD involves more than one type of exam. A thorough evaluation helps confirm the diagnosis, measure how much the eye is affected, and guide the most appropriate treatment plan.
A slit lamp is a specialized microscope that uses a focused beam of light to examine each layer of the eye. Your will look for dryness, surface damage, scarring of the conjunctiva, and any open sores on the cornea. Special yellow and green dyes may be applied to the eye to make different types of damage easier to see. The exam is painless and takes only a few minutes.
Several straightforward tests measure how well the eyes are producing and holding tears. A small paper strip placed gently under the lower eyelid measures tear volume. A dye placed on the eye shows how quickly the tear film breaks apart between blinks. Your will also observe blink rate and whether the eyelids close fully. Low scores across these tests support a diagnosis of eye GVHD.
When more detail is needed, additional imaging tools help assess the cornea. Pachymetry measures the thickness of the cornea, which can become dangerously thin in severe GVHD. Optical coherence tomography, or OCT, maps the layers of the cornea in detail. Serial photographs allow the care team to track how the eye changes over time and whether treatments are working.
Eye GVHD does not occur in isolation. Your will communicate directly with your transplant team after each visit, sharing findings and treatment notes. This coordination ensures that both body-wide GVHD drugs and eye-specific treatments are aligned with each other. A shared care approach produces the best outcomes for GVHD patients.
Treatment Options for Eye GVHD
Treatment for eye GVHD is matched to the severity of each patient's symptoms and findings. Many patients begin with conservative measures and step up to more specialized care as needed. The goal is always to protect the cornea and preserve vision while keeping the eye as comfortable as possible.
The foundation of eye GVHD management starts with preservative-free artificial tears. Because GVHD patients often need drops many times per day, preservative-free formulas prevent the irritation that preserved drops can cause with frequent use. A lubricating gel or ointment at bedtime helps maintain moisture overnight. Warm compresses and gentle eyelid cleaning help clear blocked oil glands and improve tear quality.
- Preservative-free artificial tears used throughout the day
- Lubricating gel or ointment applied at night
- Daily eyelid cleaning to reduce inflammation at the lid margins
- Warm compresses to open blocked oil glands
- A humidifier in the bedroom or workspace to reduce environmental dryness
When artificial tears alone are not enough, prescription drops are added. Cyclosporine and lifitegrast are anti-inflammatory drops that reduce the immune activity damaging the tear glands. Short courses of steroid drops can bring down an acute flare. Punctal plugs, tiny devices placed in the drainage channels of the eyelid, help keep natural tears on the eye surface for longer between drops.
For patients with severe eye GVHD, two advanced options have changed the standard of care. Autologous serum drops are made from a patient's own blood and contain growth factors that support corneal healing and surface health. Scleral lenses are large, rigid contact lenses that vault completely over the cornea and hold a reservoir of fluid against the eye surface all day. Both approaches offer meaningful relief and corneal protection in cases where standard drops fall short.
Some patients need procedural care to protect or restore the cornea. A bandage contact lens can shield a damaged surface while it heals. Amniotic membrane tissue, a thin biological material with healing properties, can be placed over the cornea to help repair deep or persistent damage. Temporary partial eyelid closure, known as a tarsorrhaphy, is sometimes used to keep the cornea moist in patients whose eyelids do not close completely. Corneal surgery is considered only when all other options have been exhausted.
The medications your transplant team uses to control systemic GVHD also influence eye health. When eye signs flare, your transplant team may adjust your overall regimen. Your will share findings and recommendations with that team to support the decision. It is important never to stop or adjust any medication on your own, as every change requires careful medical review.
Living Well With Eye GVHD
Managing eye GVHD is an ongoing process, but many patients find real comfort and stability with the right daily habits and a consistent care schedule. Small adjustments to your routine can make a meaningful difference over time.
Certain everyday choices help reduce irritation and support the eye surface. Staying well hydrated, eating foods rich in omega-3 fatty acids, and avoiding smoky or dry environments all contribute to better tear quality. Wraparound sunglasses or protective eyewear outdoors help block wind and UV light. Taking regular breaks during screen time reduces strain on already-dry eyes.
Most GVHD patients benefit from eye exams every three to six months, even when symptoms feel stable. After a flare or a change in systemic medications, scheduling a visit within a few weeks helps catch any changes before they worsen. Patients with more severe disease may need monthly monitoring for a period. Routine visits allow small problems to be addressed before they become serious.
A coordinated plan between your eye and transplant team gives you the best protection. Keeping a simple log of your eye symptoms, drop schedules, and any new or worsening signs helps every provider understand your full picture. Bring this log to each appointment and share it with both teams. Clear communication between providers reduces the chance of any concern being missed.
Frequently Asked Questions
These answers address common concerns that go beyond the general information above, including practical guidance for day-to-day decisions.
We recommend a baseline eye exam within the first few months after transplant, even if you are not experiencing any eye symptoms yet. Subtle dryness and early surface changes can be present before you notice discomfort. Having a documented baseline makes it much easier to identify meaningful changes at future visits and adjust your care plan accordingly.
Eye GVHD is often a long-term condition rather than something that clears up quickly. Some patients see gradual improvement as their overall GVHD is brought under better control, while others manage symptoms on an ongoing basis with drops, scleral lenses, or other treatments. The primary goal is to maintain a healthy corneal surface and preserve vision, even if some degree of dry eye remains. Your will help you set realistic expectations based on your specific situation.
Not all drops available without a prescription are appropriate for GVHD patients. Redness-relief drops, for example, can cause rebound redness and may further irritate an already compromised eye surface. When using drops many times a day, always choose preservative-free artificial tears specifically. Before starting any new over-the-counter product, check with your to make sure it will not interfere with your prescription drops or worsen your condition.
Standard soft contact lenses sit directly on the corneal surface and can increase dryness and discomfort in GVHD patients. Scleral lenses, by contrast, are large rigid lenses that rest on the white part of the eye and vault over the cornea entirely, leaving a space filled with sterile saline solution between the lens and the eye. This fluid-filled space continuously bathes the corneal surface throughout the day, providing sustained moisture that drops alone cannot replicate. Most patients adapt to insertion and removal within a few practice sessions with guidance from their .
Many patients with eye GVHD continue to work and drive safely with proper treatment and some adjustments. Using drops before driving or extended reading, taking regular screen breaks, and wearing anti-glare or tinted lenses on bright days can all help. If your vision is fluctuating significantly or you are experiencing sudden changes, hold off on driving until you have been evaluated. Your can help you determine what modifications best suit your lifestyle and level of vision stability.
It is worth discussing any change in eye symptoms with both your and your transplant team, even if the rest of your GVHD seems to be improving. Some patients experience eye flares during medication tapers, since lower doses of systemic drugs may reduce protection for the eye surface. Reporting a flare promptly allows both teams to assess whether a treatment adjustment is needed before the cornea is affected more seriously.
Expert Eye GVHD Care at Associated Eye Physicians & Surgeons
At Associated Eye Physicians & Surgeons, our team is experienced in evaluating and managing eye complications following transplant, including all stages of GVHD-related corneal disease. We work closely with transplant teams across New Jersey to provide coordinated, thorough care that keeps your vision and eye health at the center of your recovery. If you have had a stem cell or bone marrow transplant and have not yet had your eyes evaluated, we encourage you to schedule an appointment at one of our four convenient locations and take this important step in protecting your sight.
Right on time, friendly tech. Doctor explained procedure and answered my questions.
Dolores T.
Dr. Liva is so thorough. He explains everything and is so kind. He saved my husband’s eyesight!
Marion Knowles
This is a great place to go to, everyone there friendly, warm, very clean not a long wait. I would recommend going there. The doctor was great.
Elsie P.
Staff & doctors are very nice. Facility was clean & organized. Did not feel rushed & did not have to wait long to be seen.
Robert Burr
My experience was great the staff was amazing
Norbert Donnell